RT Journal Article
SR Electronic
T1 A Systematic Review of Peruvian Contributions to Scientific Publications on Experimental Research Against COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.03.23289455
DO 10.1101/2023.05.03.23289455
A1 Coronel-Monje, Katiusca
A1 Candia-Puma, Mayron Antonio
A1 Vilca-Alosilla, Juan Jeferson
A1 Goyzueta-Mamani, Luis Daniel
A1 Aguilar Bravo, Herbert Mishaelf
A1 Sánchez Zegarra, Jorge Augusto
A1 Barazorda-Ccahuana, Haruna Luz
A1 Ferraz Coelho, Eduardo Antonio
A1 Chávez-Fumagalli, Miguel Angel
YR 2023
UL http://medrxiv.org/content/early/2023/05/03/2023.05.03.23289455.abstract
AB One of the countries most adversely affected by the COVID-19 outbreak was Peru. Worldwide scientific knowledge creation has significantly grown because of this pandemic. This systematic study aims to examine several facets of Peru’s experimental scientific production concerning COVID-19. Between December 2019 and June 2022, searches were made in the PubMed database for experimental scientific articles created in Peruvian institutions. The systematic review resulted in nine studies that meet the requirements. Data were extracted and analyzed on the type of biomedical research, the study’s applicability, the thematic area and specific thematic, journal impact factor and quartile, funding, grants, and institution of affiliation for the first and correspondence authors. The results revealed that Peru needs to promote policies to boost research funding and the number of researchers to produce information that will be useful for managing diseases in the future. Yet, despite the funding provided by national organizations like National Council for Science, Technology, and Technological Innovation (CONCYTEC), there were few publications and little international collaboration. The studies that have been published focus mostly on applied research in the areas of diagnostics, sanitary products, and treatment and transmission, and they have great visibility because they are indexed in Q1 journals. This thorough study revealed Peru’s inadequate reaction to COVID-19 regarding experimental scientific research. Peruvian authorities should think about supporting the required policies to boost the number of researchers and financial aid to produce information that may be utilized to manage potential new diseases in the future.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by Universidad Catolica de Santa Maria (grants 27574-R-2020, and 28048-R-2021).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript https://inplasy.com/inplasy-2023-4-0080/ CONCYTECNational Council for Science, Technology, and Technological InnovationCOVID-19Coronavirus diseaseFARVET SACFarmacológicos Veterinarios SACFONDECYTNational Funding for Scientific and Technological DevelopmentINPLASYInternational Platform of Registered Systematic Review and Meta-analysis ProtocolsINSNational Health InstituteMeSHMedical Subject HeadingsNMLNational Library of MedicineNCBINational Center for Biotechnology InformationPMCPubMed CentralPMIDPubMed IdentifierPRISMAPreferred Reporting Items for Systematic Reviews and Meta-AnalysesRENACYTNational Scientific, Technological and Technological Innovation RegistrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2